Tuesday 13 October 2026
Export CLX’s income statement to Excel — free account
The Clorox Company
CLX Consumer Defensive Household & Personal Products
The Clorox Company’s revenue for fiscal 2026 (year ended June 2026) was $6.7 billion, down 5.41% from fiscal 2025. In the quarter to June 2026, revenue fell 2.01%, EPS fell 50.4%, free cash flow grew 11.4% and total debt rose 60.3%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for twenty-five consecutive years; insiders bought in the last twelve months.
84.35
0.55
+0.66%
Follow CLX
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
19.80 | 16.77 | 16.40 | 19.24 |
+8 more quarters Free account |
P/S ratio |
1.73 | 1.86 | 1.81 | 2.23 | |
P/FCF ratio |
28.70 | 33.10 | 15.76 | 23.77 | |
P/Operating CF |
35.22 | (103.09) | 39.42 | 162.58 | |
P/B ratio |
46.12 | 136.70 | 350.32 | 109.57 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
2.30 | 2.12 | 2.21 | 2.64 | |
EV/EBITDA |
13.33 | 10.96 | 11.90 | 14.30 | |
EV/Operating CF |
25.26 | 24.85 | 15.20 | 20.95 | |
EV/FCF |
38.18 | 37.66 | 19.22 | 28.10 | |
Quick Ratio |
0.34 | 0.59 | 0.38 | 0.39 | |
Current Ratio |
0.66 | 0.84 | 0.74 | 0.76 | |
Net Debt/EBITDA |
11.43 | 3.75 | 7.63 | 12.81 | |
Debt/Assets |
51.09% | 38.64% | 44.29% | 44.95% | |
Debt/Equity |
15.80 | 27.03 | 71.03 | 18.01 | |
Asset Turnover |
1.01 | 1.13 | 1.21 | 1.23 | |
Operating CF/Net income |
2.02 | (0.65) | 1.98 | 1.16 | |
Capex/Depreciation |
(1.10) | (0.74) | (0.76) | (0.64) | |
Interest Coverage |
4.69 | 10.70 | 9.64 | 5.43 | |
Research and Development Expense of Revenue |
1.64% | 1.62% | 1.73% | 1.96% | |
Selling, General and Administrative Expense of Revenue |
26.39% | 24.31% | 27.02% | 31.00% | |
Intangible Assets out of Total Assets |
0.45 | 0.28 | 0.32 | 0.32 | |
Share Based Compensation of Revenue |
(0.05%) | 0.90% | 1.43% | 0.70% | |
Graham Net Nets |
(0.49) | (0.29) | (0.31) | (0.24) | |
Graham Number |
14.98 | 10.27 | 6.31 | 12.74 | |
Earnings Yield |
5.05% | 5.96% | 6.10% | 5.20% | |
Free Cash Flow Yield |
3.48% | 3.02% | 6.35% | 4.21% | |
Revenue per Share |
16.00 | 13.76 | 13.76 | 11.65 | |
Operating CF per Share |
2.71 | (1.01) | 2.56 | 0.76 | |
Capex per Share |
(0.71) | (0.35) | (0.35) | (0.29) | |
Free Cash Flow per Share |
2.00 | (1.36) | 2.21 | 0.46 | |
Cash per Share |
1.17 | 9.78 | 1.87 | 1.35 | |
Shareholders Equity per Share |
2.07 | 0.76 | 0.29 | 1.13 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
2.07 | 0.76 | 0.29 | 1.13 | |
Free Cash Flow |
244.00 | (165.00) | 269.00 | 57.00 | |
Working Capital |
(949.00) | (504.00) | (619.00) | (539.00) | |
Capital Expenditures |
(86.00) | (43.00) | (42.00) | (36.00) | |
Net Current Asset Value |
(5,718.00) | (3,693.00) | (3,850.00) | (3,695.00) | |
EV/EBIT |
16.93 | 13.25 | 14.46 | 17.37 | |
Capex to Sales |
0.04 | 0.03 | 0.03 | 0.03 | |
Price to Operating Income |
12.73 | 11.65 | 11.86 | 14.69 | |
| Other line items | |||||
Average Receivables |
806.00 | 634.00 | 637.00 | 649.00 | |
Average Payables |
1,714.00 | 1,747.50 | 1,708.50 | 1,699.50 | |
Average Inventory |
650.00 | 611.50 | 600.00 | 585.50 | |
Average Assets |
6,677.50 | 5,974.00 | 5,595.00 | 5,512.50 | |
Average Common Equity |
367.00 | 141.00 | 78.00 | 181.00 |
Columns are period end dates